6485-55-8C[C@@H]1CNC[C@H](C)O1HNVIQLPOGUDBSU-OLQVQODUSA-N6485-55-8DTXSID00896844This chemical does not meet GHS hazard criteria for 0.6% (1 of 174) of reports.
Danger
H226 (98.9%): Flammable liquid and vapor [Warning Flammable liquids];H302 (94.3%): Harmful if swallowed [Warning Acute toxicity, oral];H312 (97.7%): Harmful in contact with skin [Warning Acute toxicity, dermal];H314 (94.8%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation];H318 (97.1%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
P210, P233, P240, P241, P242, P243, P260, P264, P264+P265, P270, P280, P301+P317, P301+P330+P331, P302+P352, P302+P361+P354, P303+P361+P353, P304+P340, P305+P354+P338, P316, P317, P321, P330, P362+P364, P363, P370+P378, P403+P235, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 174 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 1 of 174 reports by companies.;There are 12 notifications provided by 173 of 174 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
UsesCis-2,6-Dimethylmorpholine is used in the synthesis of p38α MAP kinase inhibitors used in the treatment of autoimmune diseases. Also used towards the synthesis of potent agonists and antagonists of 5-HT 4 receptors.
General DescriptionThe cis-2,6-dimethylmorpholine isomer exhibits superior fungicidal activity against a broad range of fungi compared to its trans-isomer[1][2]. This compound serves as a precursor in the synthesis of pyrazolopyrimidine mTOR inhibitors, where it replaces morpholine to yield specific derivative structures[2][3].
Loading…